RF
IDNA icon

Rossby Financial’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Rossby Financial’s Portfolio IDNA Stock Details IDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.82K Buy
291
+231
+385% +$6.93K ﹤0.01% 1182
2026
Q1 		$1.75K Buy
60
+4
+7% +$116 ﹤0.01% 1851
2025
Q4 		$1.47K Sell
56
-8
-13% -$206 ﹤0.01% 1450
2025
Q3 		$1.56K Buy
+64
New +$1.42K ﹤0.01% 1200

Other funds holding IDNA

UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
PGA
Portland Global Advisors Portland, Maine $1.05B AUM 18.22% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
TF
Trek Financial Scottsdale, Arizona $2.01B AUM 53.49% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Rossby Financial's IDNA Position: Q2 2026 in Review

Rossby Financial increased its iShares Genomics Immunology and Healthcare ETF (IDNA) stake by 385% in Q2 2026, buying an estimated $6.93K and bringing the position to 291 shares worth $9.82K. The position accounts for ﹤0.01% of the portfolio, ranked #1182.

Rossby Financial first reported a position in IDNA in Q3 2025 and has held it in 4 quarters since. 66 funds tracked by Wall St. Rank hold IDNA as of Q2 2026.

  • Rossby Financial held 291 shares of iShares Genomics Immunology and Healthcare ETF worth $9.82K as of Q2 2026.
  • Rossby Financial bought 231 iShares Genomics Immunology and Healthcare ETF shares in Q2 2026, an estimated $6.93K.
  • iShares Genomics Immunology and Healthcare ETF made up ﹤0.01% of Rossby Financial's portfolio in Q2 2026, its #1182 holding.
  • Rossby Financial first reported a position in iShares Genomics Immunology and Healthcare ETF in Q3 2025 and has held it in 4 quarters since.
  • 66 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q2 2026.

Based on Rossby Financial's 13F filing for Q2 2026, filed 4 Aug 2026.